Multi-agent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone and daratumumab (Pom-PAD-Dara) in relapsed/ refractory multiple myeloma

Autor: Zhou, Xiang, Steinhardt, Max, Grathwohl, Denise, Meckel, K., Nickel, K., Leicht, Hans-Benno, Krummenast, Franziska, Einsele, Hermann, Kortüm, K.M., Rasche, Leo
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e285-e285
Databáze: ScienceDirect
Externí odkaz: